Michael joined Atuka in 2011. He has a Ph.D. in Neuroscience, from the University of Manchester, UK (1997) and has more than 15 years’ experience in Parkinson’s disease research. Previously, he held the position of Chief Operating Officer at a CRO where he lead translational research that has supported the assessment of efficacy of more than 30 drug candidates in rodent and non-human primate models of PD, 7 of which advanced to clinical studies. These and other studies are detailed in 31 peer-reviewed publications.
In addition to his role in Atuka, Dr Hill has an academic position focused primarily on the pharmacology of Parkinson’s disease at University Health Network (2011-present).
Description & References:
Product Spec:
CAS No.:
Molecular Structure: